Striggow; Frank

Patent Applications and Registrations

Patent applications and USPTO patent grants for Striggow; Frank.The latest application filed is for "device and method for measuring impedance in organotypic tissues".

Company Profile

1.7.16

Striggow; Frank - Gerwisch DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Device and method for measuring impedance in organotypic tissues Grant 10,670,576 - Robitzki , et al.	2020-06-02
Device And Method For Measuring Impedance In Organotypic Tissues App 20170191980 - ROBITZKI; Andrea ; et al.	2017-07-06
Polymutant tau protein variants and their use for recapitulating human tauopathies Grant 9,527,894 - Robitzki , et al. December 27, 2	2016-12-27
Polymutant Tau Protein Variants And Their Use For Recapitulating Human Tauopathies App 20140162306 - Robitzki; Andrea ; et al.	2014-06-12
Novel Multifunctional Peptidase Inhibitors, Especially For Medical Use App 20120258960 - Ansorge; Siegfried ; et al.	2012-10-11
Dual alanyl aminopeptidase and dipeptidyl peptidase iv inhibitors for functionally influencing different cells and for treating immunological inflammatory, neuronal and other diseases Grant 8,263,636 - Ansorge , et al. September 11, 2	2012-09-11
Drug preparation comprising .alpha.-lipoic acid, ambroxol and/or inhibitors of the angiotensin-converting enzyme (ACE) and its use for the treatment of neurodegenerative diseases Grant 7,858,655 - Rohnert , et al. December 28, 2	2010-12-28
Method of treating cerebral ischemia with hydrogenation products of frankincense extracts Grant 7,645,461 - Striggow , et al. January 12, 2	2010-01-12
Device And Method For Measuring Impedance In Organotypic Tissues App 20090247898 - ROBITZKI; Andrea ; et al.	2009-10-01
Tissue-Based Assay System for Alzheimer-Specific Degeneration and Pathology App 20080138811 - Mack; Till ; et al.	2008-06-12
Model System for Testing the Efficacy of Pharmaceutical Preparation on Inflammatory Processes in the Nervous System App 20080118475 - Striggow; Frank ; et al.	2008-05-22
Use of inhibitors of enzymes having activities of amino peptidase N and/or dipeptidyl peptidase IV and of pharmaceutical preparations thereof for a therapy and prevention of chronical neurodegenerative diseases Grant 7,291,599 - Striggow , et al. November 6, 2	2007-11-06
Dual alanyl aminopeptidase and dipeptidyl peptidase iv inhibitors for functionally influencing different cells and for treating immunological inflammatory, neuronal and other diseases App 20070078130 - Ansorge; Siegfried ; et al.	2007-04-05
Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases App 20070037752 - Ansorge; Siegfried ; et al.	2007-02-15
Novel dipeptidyl peptidase IV inhibitors used for functionally influencing different cells and treating immunological, infammatory, neuronal, and other diseases App 20070037785 - Ansorge; Siegfried ; et al.	2007-02-15
Device and method for automatically carrying out laboratory procedure steps App 20070005169 - Rohnert; Peter ; et al.	2007-01-04
Use of incense or hydrogenation products for preventing and/or treating a cerebral ischemia and/or cerebral traumatic lesion App 20060177467 - Striggow; Frank ; et al.	2006-08-10
Vital mammalian heart tissue cells maintained ex vivo, processes of the collection and cultivation thereof and their use App 20050239039 - Goette, Andreas ; et al.	2005-10-27
Use of inhibitors of enzymes having activities of amino peptidase N and/or dipeptidyl peptidase IV and of pharmaceutical preparations thereof for a therapy and prevention of chronical neurodegenerative diseases App 20050113310 - Striggow, Frank ; et al.	2005-05-26
Drug preparation comprising alpha-lipoic acid, ambroxol and/or inhibitors of the angiotensin-converting enzyme (ACE) and its use for the treatment of neurodegenerative diseases App 20040219207 - Rohnert, Peter ; et al.	2004-11-04
Use of enzyme inhibitors of the dipeptidypeptidase iv (ec3.3.14.5) in addition to the aminopeptidase n (ec 3.4.11.2), individually or in a combination thereof, and pharmaceutical preparations thereof for the prevention and/or therapy of ischaemia-caused acute and chronic neurodegenerative process an App 20040147434 - Ansorge, Siegfried ; et al.	2004-07-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.